MCO
71
-7
DOV
65
-4
NOV
52
-5
COP
57
-2
SLB
52
-3
HRB
59
2
M
31
-3
CTAS
53
-3
SYF
86
-6
THC
60
-5
TGT
45
-4
CA
22
-3
DVN
14
-6
NSC
53
-4
STI
45
26
EA
60
-5
CINF
53
3
SNA
70
-5
LEN
50
-2
CPB
22
-5
MCO
71
-7
DOV
65
-4
NOV
52
-5
COP
57
-2
SLB
52
-3
HRB
59
2
M
31
-3
CTAS
53
-3
SYF
86
-6
THC
60
-5
TGT
45
-4
CA
22
-3
DVN
14
-6
NSC
53
-4
STI
45
26
EA
60
-5
CINF
53
3
SNA
70
-5
LEN
50
-2
CPB
22
-5
Financhill
Back

Direxion Daily Phrmctcl&MdclBl3XShrsETF Vs. Avidity Biosciences Industry Stock Comparison

Sell
30

PILL
Direxion Daily Phrmctcl&MdclBl3XShrsETF

Last Price:
8.32
Seasonality Move:
28.61%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
30
Direxion Daily Phrmctcl&MdclBl3XShrsETF (PILL) is a Sell

Is Direxion Daily Phrmctcl&MdclBl3XShrsETF a Buy, Sell or Hold?

  • The current Direxion Daily Phrmctcl&MdclBl3XShrsETF [PILL] share price is $8.34. The Score for PILL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • PILL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PILL Stock Price Chart

What is Direxion Daily Phrmctcl&MdclBl3XShrsETF's stock price today?

  • The Direxion Daily Phrmctcl&MdclBl3XShrsETF share price today is $8.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PILL is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

PILL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 39.91 Sell
Chaikin Money Flow: -89347 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.87 - 9.77) Sell
Bollinger Bands (100): (7.02 - 8.98) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

PILL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.57 Sell
20-day SMA: 9.29 Sell
50-day SMA: 8.68 Sell
200-day SMA: 7.71 Buy
8-day EMA: 9.27 Sell
20-day EMA: 9.23 Sell
50-day EMA: 8.78 Sell
200-day EMA: 7.93 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

Direxion Daily Phrmctcl&MdclBl3XShrsETF Earnings Growth & PILL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

Direxion Daily Phrmctcl&MdclBl3XShrsETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):